Search hospitals > Minnesota > Minneapolis
Abbott Northwestern Hospital
Claim this profileMinneapolis, Minnesota 55407
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Relapse
Conducts research for Cervical Adenocarcinoma
Conducts research for Cancer
500 reported clinical trials
26 medical researchers
Summary
Abbott Northwestern Hospital is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Relapse, Cervical Adenocarcinoma, Cancer and other specialties. Abbott Northwestern Hospital is involved with conducting 500 clinical trials across 631 conditions. There are 26 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Santiago Garcia, MD.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
David M. KingPark Nicollet Clinic - Saint Louis Park8 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Lung Cancer
104 reported clinical trials
167 drugs studied
Daniel M. AndersonAbbott-Northwestern Hospital6 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Cancer
61 reported clinical trials
110 drugs studied
Yan JiRegions Hospital1 year of reported clinical research
Studies Breast Cancer
Studies Parotid Gland Cancer
32 reported clinical trials
77 drugs studied
Santiago Garcia, MDThe Christ Hospital7 years of reported clinical research
Studies Congenital Aortic Stenosis
Studies Aortic Valve Disease
15 reported clinical trials
19 drugs studied
Clinical Trials running at Abbott Northwestern Hospital
Breast Cancer
Lung Cancer
Parotid Gland Cancer
Breast cancer
Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Multiple Myeloma
Ovarian Cancer
Esophageal Adenocarcinoma
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Abbott Northwestern Hospital?
Where is Abbott Northwestern Hospital located?
Who should I call to ask about financial aid or insurance network?
What insurance does Abbott Northwestern Hospital accept?
What awards or recognition has Abbott Northwestern Hospital received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.